Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Xuewen Liu(Peking University), Ying Liu(Shandong University), Pinghong Ming(Hubei University of Chinese Medicine), Qian Cheng(Peking University), Ying Dong(Second Affiliated Hospital of Zhejiang University), Yang Guo(Hubei University of Medicine), Te Zhang(Hubei University of Medicine), Wei Cao(Tianjin University of Science and Technology), Baofu Zhang(Xuzhou Medical College), Shanshan Qin(Hubei University of Medicine), Zheng Lu(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College)
Cited by 20
Related Papers
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable <i>MET</i> Gene Mutations
|Journal of Clinical Oncology|2015|343
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
|JAMA|2023|209
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136